Recruiting studies: Liver Transplant Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06718517 A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mil
Phase 1 · 5 location(s) · Ausper Biopharma Co., Ltd. · NCT07600788 Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01644903 Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Phase 4 · 2 location(s) · Camille N. Kotton, MD · NCT06958796 A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
Phase 3 · 8 location(s) · GC Biopharma Corp · NCT05686759 Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
NA · 1 location(s) · University Hospital, Grenoble · NCT06341543 A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Phase 2 · 26 location(s) · Deciphera Pharmaceuticals, LLC · NCT06619561 Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters
Phase N/A · 2 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT07079150 Effect of Preoperative Vitamin D Supplementation in Liver Transplant Recipients With Vitamin D Deficiency on Post Transp
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06736093 Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413 Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06544863 A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Phase 3 · 23 location(s) · King's College London · NCT06461208 Study of AHB-171 in Chronic Hepatitis B Participants
Phase 2 · 10 location(s) · Ausper Biopharma Co., Ltd. · NCT07630727 Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06782880 Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplant
Phase N/A · 2 location(s) · University of Turin, Italy · NCT06715046 Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989 CytOSorb TreatMent Of Critically Ill PatientS Registry
Phase N/A · 28 location(s) · CytoSorbents, Inc · NCT05146336 Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07189377 The Hepatitis C Transplant Collaborative
Phase N/A · 1 location(s) · Baylor Research Institute · NCT04493385 A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative
Phase 3 · 71 location(s) · Pierre Fabre Medicament · NCT03394365

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.